AJ

Alix Joseph

Global Sales & Marketing Director at Linxens

Lyon, Auvergne-Rhône-Alpes

Overview 

Alix Joseph is the Global Sales & Marketing Director at Linxens Healthcare, with a background as a Seed investor and Advisor for Medtech start-ups. With a strong track record in senior leadership roles at Thermo Fisher Scientific and PerkinElmer, Alix has excelled in driving global business development and market expansion within the healthcare industry.

Work Experience 

  • Global Sales & Marketing Director

    2023 - Current

    • Lead Commercial and Marketing operations for Linxens Healthcare Business Unit with active lead generation and Key account management; • Successfully integrated the Nile AB sales organization into Linxens Healthcare; • Ensure to meet KPIs for Linxens Healthcare: Revenue, P&L, Lead generation, Forecast, brand awareness; • Spearheaded the development of the Linxens Healthcare brand and its strategic market positioning; • Driving effective communication and engagement activities. • Spokesperson for Linxens Healthcare activities to the media.

  • Vice-President Healthcare (acting)

    2023 - 2024

    - Founded and structured Linxens Healthcare (50+ employees). - Led cross-functional teams: sales, marketing, R&D, operations, and M&A. - Developed the strategic roadmap and ensured the achievement of financial objectives.

  • New Venture Healthcare Director

    2022 - 2023

    • Designed and implemented the growth strategy for the healthcare sector. • Identified acquisition opportunities and market expansion strategies. • Managed and prioritized business opportunities for sustainable growth. • Established and executed an effective communication strategy.

  • Strategic Board member

    2024

  • Seed investor | Business Angel | Selection Committee

    2022

    Focusing on Medtech/Health start-ups. Taking part of selection comittee.

  • Senior Manager Business Development Global Health

    2021 - 2022

    • Built strategic partnerships with WHO, UNICEF, FIND, and UNITAID to drive innovation in diagnostics. • Developed business cases and commercialization plans for qPCR, NGS, and microbiology solutions. • Successfully launched new diagnostic products in emerging markets.

Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.

Raised $11,047,155,227.00 from National Grid.

  • Global Business Unit Director

    2018 - 2021

    I was responsible for establishing the strategy and defining the roadmap to achieve development and sales objectives. Firmly anchored in the activity of laboratory instruments in biochemistry, I have initiated a reorientation of the Business Unit in order to broaden horizons by developing Point-of-Care systems as well as molecular tests. My key assignements were: • Developed and implemented a strategic roadmap to drive revenue growth and achieve sales objectives within the business unit; • Cultivated strong relationships with key opinion leaders in obstetrics on a global scale; • Led market access initiatives with organizations affiliated with the WHO and other NGOs; • Spearheaded a strategic reorientation of the business unit by developing innovative point-of-care and molecular testing solutions; This has resulted in particular in a 3-year collaboration with the FIGO (International Federation of Obstetric & Gynecology) with the aim of establishing international guidelines for the management of pre-eclampsia, as well as an extended collaboration with the American Society of Hematology with the aim of develop newborn screening for sickle cell disease in Africa.

  • Market Development Manager EMEA

    2016 - 2018

    • Spearheaded commercial growth strategies and drove the expansion of the diagnostics portfolio into new geographic markets Major achievements: • Forged a strategic partnership with Mobidiag Oy to expand infectious disease testing capabilities in Africa; • Identified and successfully secured a minority equity investment in Nightingale Health to strengthen the diagnostics portfolio; • Established a collaborative agreement with Sophia Genetics to complement the next-generation sequencing portfolio and drive growth;

  • Segment Leader chemagen

    2015 - 2016

    Through this role held in parallel with the position of Sales Director, my mission was to coordinate sales and marketing activities in Europe in order to ensure consistency with sales strategies, and to provide sales teams with visibility on competitors activities in the sector.

  • Sales Director Diagnostics France, French Speaking Africa and South Africa

    2013 - 2016

    This role with P&L control consisted of managing the sales forces, support engineers and service engineers for Diagnostics customers in France and South Africa. I was thus able to lead and supervise teams, set up sales and support structures in Africa as well as develop a distribution network over a large part of the African continent. Key responsabilities: • Overseen the financial performance of the entire Diagnostics portfolio; • Led sales and service operations in France and Africa with more than 11 collaborators and a distributors;; • Managed and coordinated chemagen (NAP) sales and marketing activities across the EMEA region Major achievements: • Successfully launched newborn screening programs in the Maghreb region; • Achieved consistent year-over-year revenue growth in established markets: Also in charge of maintaining relationships with opinion leaders in order to maintain a leading position in our key markets (prenatal and newborn screening), and also to allow the emergence of new high growth segments in molecular testing.

  • Sales & Support Manager Molecular Diagnostics EMEA

    2011 - 2013

    I was invited through this role to create and lead the first EMEA sales and support structure within PerkinElmer with the aim of supporting the development of the company in this new high growth sector. Key reposnsabilities: • Founded and led the inaugural EMEA Molecular Diagnostics sales and support organization (10 collaborators + distributors); • Successfully integrated chemagen Gmbh into PKI's organizational structure. • Managed and developed a robust EMEA distribution network. • Developped the PerkinElmer brand in a new sector and define commercial launch strategies for many new products (Fragile-X, microarrays, DNA/RNA extraction)

  • Sales Specialist Molecular Diagnostics Europe

    2008 - 2011

    • Responsible for Molecular Diagnostics products sales and development in a large region: France, Spain, Italy (since 2010), Portugal and North Africa. • Define with local teams the strategy to introduce new products into every single country in my region. • Provide technical knowledge, support and training in France, Spain, Portugal, Italy, United Kingdom and North Africa. • Manage and organize marketing activities has congress and workshop. • Help to develop and improve current product (develop new protocols) • First region in Europe in terms of sales in Molecular Diagnostics product in 2009. • First region in Europe having sales in the new BACs-on-Beads platform. • Provide sales and marketing trainings to local sales team on Molecular Diagnostics product line.

  • Sales Specialist Molecular Diagnostics France

    2008 - 2008

    • Responsible in Molecular Diagnostics development in France. • Responsible for technical training and support on Molecular Diagnostics products. • Mange organization of marketing events in France for Molecular Diagnostics.

  • Account Manager Genetic Screening France North

    2007 - 2008

    • Responsible for sales of all Genetic Screening products for North of France. • Introduce Molecular Diagnostics products to the French market • Provide high technical level trainings on DELFIA Xpress instrument for Prenatal screening

Articles About Alix

Relevant Websites